PEN
Penumbra, Inc. NYSE$324.65
Mkt Cap $12.8B
52w Low $221.26
73.2% of range
52w High $362.41
50d MA $333.99
200d MA $295.21
P/E (TTM)
71.2x
EV/EBITDA
54.5x
P/B
8.9x
Debt/Equity
0.1x
ROE
12.4%
P/FCF
69.2x
RSI (14)
—
ATR (14)
—
Beta
0.84
50d MA
$333.99
200d MA
$295.21
Avg Volume
665.7K
About
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components a…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 1.11 | 1.18 | +6.3% | 338.67 | +0.3% | +1.0% | +1.7% | +1.1% | +0.4% | +0.3% | -1.1% | — |
| Nov 5, 2025 | AMC | 0.93 | 0.97 | +4.4% | 225.54 | +15.2% | +17.3% | +18.0% | +20.0% | +24.0% | +24.3% | +33.3% | — |
| Jul 29, 2025 | AMC | 0.81 | 0.86 | +6.2% | 227.15 | +8.7% | +11.9% | +11.1% | +7.0% | +5.8% | +5.7% | +19.6% | — |
| Apr 23, 2025 | AMC | 0.66 | 0.83 | +25.8% | 278.77 | +7.6% | +7.0% | +7.5% | +6.7% | +6.5% | +5.0% | -3.7% | — |
| Feb 18, 2025 | AMC | 0.88 | 0.97 | +10.2% | 271.14 | +9.2% | +12.0% | +11.8% | +7.6% | +6.1% | +3.9% | +3.8% | — |
| Oct 30, 2024 | AMC | 0.69 | 0.85 | +23.2% | 211.29 | -1.8% | +8.3% | +10.4% | +8.6% | +10.0% | +10.6% | +15.5% | — |
| Jul 30, 2024 | AMC | 0.56 | 0.64 | +14.3% | 173.09 | -12.2% | -3.5% | -1.1% | +1.4% | +2.6% | -1.0% | +16.9% | — |
| May 7, 2024 | AMC | 0.42 | 0.41 | -2.4% | 210.00 | -1.9% | -3.3% | -0.3% | +1.1% | -2.5% | -0.6% | -6.5% | — |
| Feb 22, 2024 | AMC | 0.71 | 0.76 | +7.0% | 262.68 | -8.9% | -9.3% | -12.0% | -11.6% | -12.2% | -10.6% | -16.2% | — |
| Nov 2, 2023 | AMC | 0.46 | 0.67 | +45.7% | 198.26 | +0.1% | -0.2% | +0.2% | -0.9% | -3.9% | -7.3% | +15.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 | Evercore ISI | Maintains | Outperform → Outperform | — | $338.67 | $339.83 | +0.3% | +1.0% | +1.7% | +1.1% | +0.4% | +0.3% |
| Jan 20 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $350.78 | $350.80 | +0.0% | +1.3% | +2.0% | +2.2% | +2.4% | +2.3% |
| Jan 20 | Canaccord Genuity | Downgrade | Buy → Hold | — | $350.78 | $350.80 | +0.0% | +1.3% | +2.0% | +2.2% | +2.4% | +2.3% |
| Jan 16 | Jefferies | Downgrade | Buy → Hold | — | $350.49 | $349.99 | -0.1% | +0.1% | +1.4% | +2.1% | +2.3% | +2.5% |
| Jan 16 | Truist | Downgrade | Buy → Hold | — | $350.49 | $349.99 | -0.1% | +0.1% | +1.4% | +2.1% | +2.3% | +2.5% |
| Jan 16 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $350.49 | $349.99 | -0.1% | +0.1% | +1.4% | +2.1% | +2.3% | +2.5% |
| Jan 16 | BTIG | Downgrade | Buy → Neutral | — | $350.49 | $349.99 | -0.1% | +0.1% | +1.4% | +2.1% | +2.3% | +2.5% |
| Jan 16 | Baird | Downgrade | Outperform → Neutral | — | $350.49 | $349.99 | -0.1% | +0.1% | +1.4% | +2.1% | +2.3% | +2.5% |
| Jan 16 | Needham | Downgrade | Buy → Hold | — | $350.49 | $349.99 | -0.1% | +0.1% | +1.4% | +2.1% | +2.3% | +2.5% |
| Jan 16 | Citigroup | Downgrade | Buy → Neutral | — | $350.49 | $349.99 | -0.1% | +0.1% | +1.4% | +2.1% | +2.3% | +2.5% |
Recent Filings
Data updated apr 26, 2026 7:13pm
· Source: massive.com